Decade of quality-driven accelerated development of innovative drugs in China and its implications worldwide
Crossref DOI link: https://doi.org/10.1007/s11427-025-3245-8
Published Online: 2026-03-16
Published Print: 2026-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Yale
Hou, Yiru
Fang, Hong
Tang, Yu
Huang, Huiyao
Li, Ning
Text and Data Mining valid from 2026-03-16
Version of Record valid from 2026-03-16
Article History
Received: 16 October 2025
Accepted: 27 January 2026
First Online: 16 March 2026
Compliance and ethics
: The authors declare that they have no conflict of interest.